on AMOEBA (EPA:ALMIB)
Amoéba and Koppert enter into a distribution agreement for an innovative biofungicide
Amoéba, a French greentech company, and Koppert, a global leader in biological protection, have signed a distribution agreement for an innovative biofungicide based on the lysate of the amoeba Willaertia magna. This biofungicide aims to protect vineyards and market garden crops in 18 European countries and the United States. The launch is scheduled for early 2026. Koppert will distribute the product under its own brand.
The two companies also plan to collaborate on the development of new biofungicide solutions. This could provide growth opportunities and strengthen their commitment to sustainable agriculture.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AMOEBA news